PharmAthene is engaged in the development and commercialization of medical countermeasures against biological and chemical threats in the U.S. Its product candidates include SparVax, an anthrax vaccine that has completed a phase IIb clinical trials; Valortim, which has completed a phase I clinical trial for the prevention and treatment of anthrax infection; and rBChE, for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents. For more information, visit the company’s Web site at: www.pharmathene.com

Noble Financial Capital Markets, an equity research driven, full-service, investment banking boutique, is hosting its ninth annual equity conference at The Hard Rock Hotel in Ft. Lauderdale, FL. Attended by institutional investors from across North America, the event features 135 public company executive teams with an emphasis on healthcare, technology, defense, and new-media / entertainment sectors.

Let us hear your thoughts below: